MIRA INFORM REPORT

 

 

Report Date :

06.02.2007

 

IDENTIFICATION DETAILS

 

Name :

SOFTGEL HEALTHCARE PRIVATE LIMITED

 

 

Registered Office :

No. 18, Dr. Nair Road, T. Nagar, Chennai – 600 017, Tamilnadu, India.

 

 

Country :

India

 

 

Financials (as on) :

31.03.2006

 

 

Date of Incorporation :

23.01.2003

 

 

Com. Reg. No.:

18-051829

 

 

CIN No.:

[Company Identification No.]

U24231TN2003PTC051829

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

CHES20646D

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Medicines (Soft Gelatin Capsules)

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

 

Maximum Credit Limit :

 

 

 

Status :

Moderate

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. Profit margin is under severe pressure. Payments are reported as slow but correct. The company has been financially assisted by it’s bankers.

 

It can be considered normal for business dealings at usual trade terms and conditions with slight caution, initially.

 

LOCATIONS

 

Registered Office :

No. 18, Dr. Nair Road, T. Nagar, Chennai – 600 017, Tamilnadu, India.

Tel. No.:

91-44-42048590

Mobile No.:

91-9841033636

Fax No.:

91-44-42048597

 

DIRECTORS

 

Name :

Mr. A.M. Sulaiman

Designation :

Director

Address :

No. 18, Dr. Nair Road, T. Nagar, Chennai – 600 017, Tamilnadu, India.

Date of Appointment :

23.10.2003

 

 

Name :

Mr. Sidharth Baid

Designation :

Director

Address :

No. 19, Haddows Road, Chennai – 600 006, Tamilandu, India.

Date of Appointment :

23.10.2003

 

 

Name :

Dr. M. Venkata Ganesh

Designation :

Director

Address :

No. 31/59, 1st Main Road, Vijaya Nagar, Velachery, Chennai – 600 042, Tamilandu, India.

Date of Appointment :

23.10.2003

 

 

Name :

Dr. T. Palaniappan

Designation :

Director

Address :

16, Venkatnarayana Road, T. Nagar, Chennai – 600 017, Tamilandu, India.

Date of Appointment :

23.10.2003

 

 

Name :

Mr. Harjeet Singh Anand

Designation :

Director

Address :

234, 6th Main Road, Anna Nagar, Chennai – 600 040, Tamilandu, India.

Date of Appointment :

23.10.2003

 

 

Name :

Mr. V. Venkatraman

Designation :

Director

Address :

No. 5, malay Road, 30, Vasanth Apartments, T. Nagar, Chennai – 600 017, Tamilnadu, India.

Date of Appointment :

10.08.2004

 

 

Name :

Mr. A. L. Gandhimathi

Designation :

Director

Address :

10, A, VOC, 2nd Main Road, Kodambakkam, Chennai – 600 018, Tamilnadu, India.

Date of Appointment :

10.08.2004

 

MAJOR SHAREHOLDERS

 

Names of Shareholders

No. of Shares

A. M. Sulaiman

270000

Sidharth Baid

220000

Dr. M. Venkata Ganesh

270000

Dr. T. Palaniappan

270000

Harjeet Singh Anand

130000

Ravinder Singh Anand

130000

S. Geetha

40000

V. Uma Maheswari

100000

V. Veena

20000

V. Vani

50000

Jamuna Venkatraman

170000

Arun Venkatraman

50000

V. Venkatraman

50000

N. Meenakshy

270000

B. Mangaleswari

100000

A.L. Gandhimathi

270000

S. Manohar

440000

Narendra Kumar Baid

50000

Hari Balachandran

270000

M. N. Kamaludden

150000

Venkatachalam Natarajan

320000

 

 

TOTAL:

3700000

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Medicines (Soft Gelatin Capsules)

 

GENERAL INFORMATION

 

No. of Employees :

80

 

 

Bankers :

Indian Overseas Bank, C & C Branch, Mylapore, Chennai – 600 014, Tamilnadu, India.

 

 

Facilities :

--

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

B. Srinivasan

Chartered Accountant

Address:

No. 3, Play Ground View Street, Nandanam Extension, Chennai – 600 035, Tamilnadu, India.

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

10000000

Equity Shares

Rs. 10/- each

Rs. 100.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

5520000

Equity Shares

Rs. 10/- each

Rs. 55.200 Millions

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

55.200

37.000

2] Share Application Money

 

20.150

0.000

3] Reserves & Surplus

 

0.000

0.000

4] (Accumulated Losses)

 

(1.197)

0.000

NETWORTH

 

74.153

37.000

LOAN FUNDS

 

 

 

1] Secured Loans

 

143.610

46.101

2] Unsecured Loans

 

0.000

0.796

TOTAL BORROWING

 

143.610

46.897

DEFERRED TAX LIABILITIES

 

0.000

0.000

 

 

 

 

TOTAL

 

217.763

83.897

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

219.531

80.939

Capital work-in-progress

 

0.000

0.000

 

 

 

 

INVESTMENT

 

0.000

0.000

DEFERREX TAX ASSETS

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

1.712

0.000

 

Sundry Debtors

 

3.314

0.000

 

Cash & Bank Balances

 

2.422

2.822

 

Other Current Assets

 

0.000

0.000

 

Loans & Advances

 

8.898

2.070

Total Current Assets

 

16.346

4.892

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

 

18.448

2.271

 

Provisions

 

0.082

0.000

Total Current Liabilities

 

18.530

2.271

Net Current Assets

 

(2.184)

2.621

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.416

0.337

 

 

 

 

TOTAL

 

217.763

83.897

 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

 

 

31.03.2006

Sales Turnover [including other income]

 

 

150.000

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Name of the Company

SOFTGEL HEALTHCARE PRIVATE LIMITED

Presented by

Mr. Sidharth Baid

1. Date and description of the instrument

    creating  or evidencing the charge  

29th July 2004 – Letter of Hypothecation

2. Amount secured by the charge /amount  

    owing on security of the charge

 

Rs. (In Millions)

Term Loan

76.000

Letter of Gurantee

7.000

 

83.000

3. Short Particular of the property charged. If

    the property acquired is subject to change

   date of acquisition of property should be

   given 

First Charge on the entire block assets of the company including 1.96 acres of land at Vandalur-Kelambakkam Main Road, Date of Acquisition – 30th October 2003.

4. Gist of the terms and conditions and extent

    and operation of the charge.

The borrower promises and undertakes to repay the amount of the said loan in 24 quarterly instalments starting from June, September 2005. 1-23 Instalments=Rs. 3.167 Millions from July, September 2005. 24th Installment = Rs. 3.159 Millions.

 

The Borrower shall, so long as the loan remains unpaid to the bank pay interest at BPLR which is presently @11% p.a. on thr last days of March, June, September & December each year and with in 7days.

 

In case there is default of instalment payment bank shall be entitled to charge interest at 2% over rate mentioned above.

 

That the securities described in the schedule are hereby hypothecated to the bank as security for all monies for time being owing by the borrower to the Bank. The term machinery goods shall include those already fixed/lying loose in the premises of kudupakkam village and those hereafter fixed. First charge is on the entire block assets of the Co. 1.96 acres of land at Vandalur-Kalambakkam Main Road.

5. Names, address and description of the 

    persons entitled to charge

Indian Overseas Bank, C & C Branch, Mylapore, Chennai – 600 014, Tamilnadu, India.

6. Date and brief description of instrument

    modifying the charge

N.A.

7. Particular of modification specifying the

    terms and conditions or the extent or   

    operation of the charge in which

    modification is made and the details of

    modification

N.A.

 


PRESS CLIPPING:

 

Softgel Healthcare starts new plant


Thursday, March 16, 2006 08:00 IST

 
Gireesh Babu, Chennai


Softgel Healthcare Pvt. Ltd., an associate of Madras Pharmaceuticals Ltd, engaged in softgel manufacturing, has commissioned its manufacturing plant exclusively for contract manufacturing, focusing on regulated markets.


The new plant at Vandalur-Kelambakkam Road, in an area of 65,000 sq. ft., has complied with WHO-GMP certification and will manufacture softgel capsules for overseas costumers. The plant with a capacity of 120 to 150 crore capsules per annum, set up at an investment of Rs 25 crore will also be opting for advanced regulatory approvals from authorities of US, UK, Canada, Brazil and Australia, informed Sidharth Baid, executive director, Softgel Healthcare.


"The global market is in need of such contract manufacturing units with certification from regulatory authorities of the regulated markets. Our first plan is to double the capacity of the plant within a year. The company expects that the plant will get approval from US FDA within a period of 18 months," added Sidharth.

Softgel offers four manufacturing lines for two pharmaceuticals and two nutraceuticals each consisting of dedicated HVAC system and imported machinery from South Korea. All manufacturing activities are done under the worldwide norm of Class 10,000 condition, according to the company. The company also plans to double its manufacturing lines with two pharmaceuticals and two neutraceuticals with the capacity expansion, informed Sidharth.

 


CMT REPORT [Corruption, Money laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 44.09

UK Pound

1

Rs. 86.84

Euro

1

Rs. 57.21

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

-

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

4

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

38

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)                  Ownership background (20%)                         Payment record (10%)

Credit history (10%)                            Market trend (10%)                                             Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions